Exchange: NASDAQ·Updated 07:53 PM EDT
XNCR logo

XNCR Xencor Inc

$28.44
$0.86
(2.94%)
Today
Closed $28.44
$0.14
(0.49%)
After Hours
Reported EarningsAug 5
Mkt Cap$2.18B
Vol2.12M

About XNCR

Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Pasadena, CA.
58

Bullish Sentiment

How do you feel about XNCR?

Advertisement|Remove ads.